Proteostasis shares shattered as weak triplet data inspires a scorching backlash
You almost have to pity Proteostasis $PTI today. The micro-cap biotech sallied out into the stock market early in the day trying to float some …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.